Jonathan L. Wahl

Statistics

Publications

Citations

302

H-Index

Active since

2010

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

The Ohio State University

Sidney Kimmel Comprehensive Cancer Center

Jonathan L. Wahl is an author at Dana-Farber Cancer Institute specializing in medicine, acute myeloid leukemia treatment, and maintenance therapy trials.

ORCID

Publications per year

2010–2023

Publications

Management and Outcomes after Multiple Corneal and Solid Organ Transplantations from a Donor Infected with Rabies Virus

Tanja Maier, Andreas Schwarting, D. Mauer et al. · Clinical Infectious Diseases · 2010 · 132 citations · Full text

Medicine, Infectious Diseases, Surgery +17

Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for <i>IDH2</i>-mutated myeloid malignancies

Amir T. Fathi, Haesook T. Kim, Robert J. Soiffer et al. · Blood Advances · 2022 · 58 citations · Full text

Medicine, Hematology, Oncology +17

Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i> -Mutated Acute Myeloid Leukemia

Amir T. Fathi, Haesook T. Kim, Robert J. Soiffer et al. · Clinical Cancer Research · 2023 · 50 citations

Medicine, Hematology, Pharmacology +14

A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease

Jennifer Whangbo, Sarah Nikiforow, Haesook T. Kim et al. · Blood Advances · 2022 · 37 citations · Full text

Life Sciences, Immunology, Immunoregulation +13

Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease

Zhonghui Luo, Edgar A. Domenech-Estarellas, Amy Han et al. · Transplantation and Cellular Therapy · 2021 · 15 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +9

1–5 of 6